V
V. Wee Yong
Researcher at University of Calgary
Publications - 276
Citations - 21024
V. Wee Yong is an academic researcher from University of Calgary. The author has contributed to research in topics: Multiple sclerosis & Microglia. The author has an hindex of 73, co-authored 233 publications receiving 17556 citations. Previous affiliations of V. Wee Yong include Allen Institute for Brain Science & Foothills Medical Centre.
Papers
More filters
Journal ArticleDOI
Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
TL;DR: The results suggest that CaMKII-mediated pathways prevent TRAIL-induced apoptosis in human astrocytes under conditions in which TRAIL death receptors are upregulated.
Journal ArticleDOI
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.
Astrid De Boeck,Bo Young Ahn,Charlotte D'Mello,Xueqing Lun,Shyam V Menon,Mana Alshehri,Mana Alshehri,Frank Szulzewsky,Yaoqing Shen,Lubaba Khan,Ngoc Ha Dang,Elliott Michael Reichardt,Kimberly-Ann R. Goring,Jennifer King,Cameron J. Grisdale,Natalie Grinshtein,Dolores Hambardzumyan,Karlyne M. Reilly,Michael D. Blough,J. Gregory Cairncross,V. Wee Yong,Marco A. Marra,Steven J.M. Jones,David L. Kaplan,Kathy D. McCoy,Eric C. Holland,Pinaki Bose,Jennifer A. Chan,Stephen M. Robbins,Donna L. Senger +29 more
TL;DR: It is found that IL-33 expression in a large subset of human glioma specimens and murine models correlates with increased tumor-associated macrophages/monocytes/microglia, which supports the paradigm that recruitment and activation of immune cells, when instructed appropriately, offer a therapeutic strategy that switches the focus from the cancer cell alone to one that includes the normal host environment.
Journal ArticleDOI
T Cell Exhaustion in Glioblastoma: Intricacies of Immune Checkpoints
TL;DR: How immune checkpoints drive exhaustion in T cells while favoring tumor metabolism, and how glucose competition in the unique CNS milieu is an important consideration to improve the outcomes of immune checkpoint blockade in glioblastoma are reviewed.
Journal ArticleDOI
The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase
TL;DR: In vivo and at asymptomatic stages following intracerebral implant of cells, mice harboring MT2-MMP siRNA downregulated clones had smaller and less invasive tumors compared with mice implanted with non-specific siRNA control cells.
Journal ArticleDOI
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.
Suhayl Dhib-Jalbut,Douglas L. Arnold,Don W. Cleveland,Mark Fisher,Robert M. Friedlander,M. Maral Mouradian,Serge Przedborski,Bruce D. Trapp,Tony Wyss-Coray,V. Wee Yong +9 more
TL;DR: In most disorders, it remains uncertain whether inflammation and protein aggregation are neurotoxic or neuroprotective, so elucidating the mechanisms that orchestrate neuronal diseases should facilitate development of neuroProtective and neurorestorative strategies.